These Factors ‘Could Drive Gold and Silver Prices Much Higher’
Source: Crescat Capital for Streetwise Reports��(9/22/21)
In a Sept. 10, 2021 Crescat Capital broadcast from the Precious Metals Summit in Beaver Creek, the firm's Portfolio Manager, Tavi Costa, and its Chief Investment Officer, Kevin Smith, talked about the current macroeconomic environment and highlighted the opportunity in gold and silver mining equities. More >

Dynavax Shares Shoot Up 30% After Its Partner Clover Biopharma Met All Key Efficacy Endpoints in Ph. 2/3 COVID-19 Vaccine Trial
Source: Streetwise Reports��(9/22/21)
Shares of Dynavax Technologies Corp. established a new 52-week high after the company reported that in the global Phase 2/3 SPECTRA COVID-19 vaccine study its collaborative partner Clover Biopharmaceuticals met all primary and secondary efficacy endpoints. Clover's vaccine, which was developed using Dynavax's CpG 1018 adjuvant, demonstrated 100% efficacy against severe COVID-19 and 84% efficacy against moderate-to-severe COVID-19 caused by any strain of SARS-CoV-2, including the Delta, Gamma, and Mu variants. More >

Getchell Hits Substantive Gold Mineralization From First Hole of 2021 Drill Program at Fondaway Canyon
Source: Streetwise Reports��(9/21/21)
Assays from Getchell Gold’s first drill hole of 2021 support the company’s “high expectations” for its Fondaway Canyon gold project. More >

Shares of Norseman Silver Are Perfectly Positioned For a Fall Rally
Source: Mike Swanson for Streetwise Reports��(9/21/21)
Mike Swanson, the editor of WallStreetWindow.com tells Streetwise Reports that small-cap exploration stock Norseman Silver is projected to have a fall end-of-the-year rally. Here's why. More >

'Poised for Two Key Readouts in Q1/22' as Biopharma Advances Pipeline
Source: Streetwise Reports��(9/21/21)
Rezolute's two drug candidates, one for congenital hyperinsulinism and the other for diabetic macular edema, are discussed in an H.C. Wainwright & Co. report. More >

Low-Carbon Energy Firm Develops Low-Cost Electrolyzer to Produce Hydrogen for Zero-Emission Boilers
Source: Streetwise Reports��(9/21/21)
Research Capital Corp. mentioned in a recent presentation that Jericho Energy Ventures Inc. has developed a next generation hydrogen-based boiler that combines pure hydrogen and pure oxygen to generate heat, hot water, and high temperature steam through a zero-emission, closed-loop process.
More >

Inotiv Makes $545 Million Bid for Envigo RMS Holdings to Fortify Research and Drug Discovery Platforms
Source: Streetwise Reports��(9/21/21)
Shares of Inotiv Inc. traded 27% higher to a new 52-week high after the company reported it entered into agreement to acquire Envigo RMS Holding Corp. in a cash and stock deal valued at $545 million which will serve to create a one-stop-shop, discovery-to-approval solution for drug developers. More >

Two Analysts See Positives in E2Gold's Hemlo-Like Project
Source: Streetwise Reports��(9/20/21)
"All the pieces are in place for a new bull market in gold to develop” for this small-cap gold exploration company with operations in Northern Ontario. More >

Property With ‘World-Class Deposits’ and Nine Other Explorations to Watch
Source: Crescat Capital for Streetwise Reports��(9/20/21)
During Crescat Capital's Sept. 3, 2021 broadcast, Quinton Hennigh, Geologic and Technical Director of Crescat Capital, provided updates and commented on 10 companies in the firm's exploration portfolio. More >

Target Price Raised on Biopharma After It Acquires Company, Splits Stock
Source: Streetwise Reports��(9/20/21)
AzurRx BioPharma now has five additional shots on goal "with the imminent full acquisition of just one compound," a ROTH Capital Partners report noted. More >

Vior Prepares To Drill Prospective Belleterre Gold Project; Samples Return Strong Results Up to 274.9g/t Au
Source: The Critical Investor for Streetwise Reports��(9/20/21)
The Critical Investor explains why he thinks Vior (TSXV:VIO) has a good risk/reward investment profile, with its flagship Belleterre in Quebec, which contains the historic Belleterre Mine (produced 750koz Au @ 10.7g/t Au between 1936 and 1959), and very recently provided excellent sampling results, with results up to 274.9g/t Au. More >

Edessa Biotech Shares Rise 87% on Positive Findings in Phase 2 Monoclonal Antibody COVID-19 Study
Source: Streetwise Reports��(9/20/21)
Edesa Biotech Inc. shares reached a new 52-week high after the company reported positive results from its Phase 2/3 monoclonal antibody study in hospitalized COVID-19 patients. More >

Innate Pharma Shares Rise After AstraZeneca Presents Positive Data From NSCLC Trial to European Conference
Source: Streetwise Reports��(9/18/21)
Innate Pharma S.A. shares traded 38% higher after the company reported its development partner AstraZeneca Plc. reported positive interim results from its Phase 2 COAST Study to the European Society for Medical Oncology Congress. When taken together with durvalumab, monalizumab was shown to improve progression-free survival and objective response rates in patients with unresectable, Stage III non-small cell lung cancer. More >

Explorer's Sampling Efforts Indicate High-Grade Uranium and REE Deposits at Saskatchewan Property
Source: Streetwise Reports��(9/17/21)
Red Cloud Securities Inc. stated in a research report that high-grade samples exceeding 50% U3O8 at Skyharbour Resources Ltd.'s Hook Lake property provide a clear indication that a high-grade uranium zone may be located close by. Red Cloud said it is maintaining its "Speculative Buy" rating for Skyharbour and 12-month price target of CA$0.95/share. More >

'An Insane Excessive Stock Market Bubble Today,' Current Overvaluation in the Market
Source: Streetwise Reports��(9/16/21)
In a Sept. 3, 2021 broadcast, two Crescat Capital representatives discussed the current macroeconomic environment. Portfolio Manager, Tavi Costa, highlighted the bearish part of the picture along with investment opportunities with bullish potential. Chief Investment Officer, Kevin Smith, presented evidence of an overvalued equity market and noted what that means for the precious metals sector. More >

Leap Therapeutics Shares Skip Higher on Positive Preliminary Data From Gastric Cancer Study
Source: Streetwise Reports��(9/16/21)
Shares of Leap Therapeutics Inc. traded 38% higher after the company reported positive preliminary data from the Phase 2a DisTinGuish Study of DKN-01 plus tislelizumab at the European Society for Medical Oncology Congress. More >

Drill Results Demonstrate the 'Tremendous Gold Potential' of the Williams Brook Gold Project
Source: Streetwise Reports��(9/15/21)
Puma Exploration intersected 5.55 grams/tonne of gold over 50.15 meters starting at surface on its Williams Brook Gold Project. More >

The Top Three Things Affecting the Rising Inflation Thesis
Source: Streetwise Reports��(9/15/21)
In a recent Crescat Capital briefing, Portfolio Manager Tavi Costa presented current financial metrics that are expected to affect the rising inflation thesis. Also, Chief Investment Officer Kevin Smith discussed his firm's view that the current market is creating an equity bubble and highlighted catalysts that could burst it. More >

Lakewood Exploration: Silver Strand 43-101, Exploration, Adds Two Silver Projects in Nevada
Source: Maurice Jackson for Streetwise Reports��(9/15/21)
Joining us is Morgan Lekstrom, the CEO of Lakewood Exploration, which is on track to become the next pure silver play in the US. In this interview, Mr. Lekstrom discusses the latest update on the pending NI43-101 on the flagship Silver Strand, along with current exploration successes and new additions to the property bank, both in the prolific Hamilton District of Nevada, which are the Eliza Silver Project and Silverton Silver Mine, and we will conclude with pending catalysts. More >

Echoes of the 1970s Haunt Modern Markets
Source: Michael Ballanger for Streetwise Reports��(9/15/21)
Sector expert Michael Ballanger explores how modern financial times mirror his formative years in the 1970s. More >

French Biotech Firm Initiates Pivotal Phase 3 Study of Lanifibranor in 900 NASH Patients
Source: Streetwise Reports��(9/15/21)
ROTH Capital Partners LLC advised in a research report that Inventiva S.A. has initiated enrollment in its highly anticipated pivotal Phase 3 Study of Lanifibranor in individuals diagnosed with nonalcoholic steatohepatitis. ROTH rates Inventiva a "Buy" with a 12-month price target of €55/share which represents a nearly four-fold increase over the current share price. More >

Instil Bio Receives FDA Approval to Initiate Expanded Phase 2 Advanced Melanoma Study
Source: Streetwise Reports��(9/15/21)
Shares of Instil Bio Inc. traded 16% higher after the company reported it received IND clearance from the U.S. FDA to initiate a Phase 2 clinical trial in advanced melanoma patients. More >

'Bona Fide Discovery' in Early Drilling at a Yukon Gold Project
Source: Streetwise Reports��(9/14/21)
In a recent broadcast, Geologic and Technical Director to Crescat Capital, Dr. Quinton Hennigh, provided updates on three exploration companies with recent news and covered seven other exploration stories of note. More >

Biopharma Co. Posts Positive Objective Response & Disease Control Rates in Ovarian Cancer Studies
Source: Streetwise Reports��(9/14/21)
H.C. Wainwright & Co. advised in a research report that updated data from Mersana Therapeutics Inc.'s expansion study supports its UPLIFT Study and will provide the basis for a new Phase 3 study in 2022. H.C. Wainwright rates Mersana a "Buy" with a target price of $28.00/share. More >

Streetwise Live! Presents Heliostar Metals
Source: Streetwise Reports��(9/14/21)
Streetwise Live! Presents Heliostar Metals Ltd. Featuring Charles Funk, CEO and Director of Heliostar Metals Ltd., Adrian Day of Adrian Day Asset Management, and Joe Mazumdar, Editor/Analyst and Publisher of Exploration Insights. More >